Choosing the right pharmacotherapy for non-Hodgkin's lymphoma: does one size fit all?

Expert Opin Pharmacother. 2019 May;20(7):773-775. doi: 10.1080/14656566.2019.1582643. Epub 2019 Feb 22.

Authors

Taha Al Juhaishi¹, Victor Yazbeck^{1

2}

Affiliations

¹ a Department of Internal Medicine , Virginia Commonwealth University , Richmond , VA , USA.
² b Massey Cancer Center , Virginia Commonwealth University , Richmond , VA , USA.

PMID: 30793985
DOI: 10.1080/14656566.2019.1582643

No abstract available

Keywords: Targeted therapy; biomarker; hemoimmunotherapy; non-Hodgkin’s lymphoma; precision medicine.

Publication types

Editorial